Congenital heart defects in children born after assisted reproductive technology: a CoNARTaS study.

In vitro fertilization Assisted reproductive technology Congenital heart defects Frozen embryo transfer Intracytoplasmic sperm injection Registry-based study

Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
26 Sep 2024
Historique:
received: 02 02 2024
revised: 23 04 2024
accepted: 17 08 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 26 9 2024
Statut: aheadofprint

Résumé

Children born after assisted reproductive technology (ART) have worse perinatal outcomes compared with spontaneously conceived children. This study investigates whether children conceived after ART have a higher risk of congenital heart defects (CHDs) compared with children born after spontaneous conception (SC). All 7 747 637 liveborn children in Denmark (1994-2014), Finland (1990-2014), Norway (1984-2015), and Sweden (1987-2015), where 171 735 children were conceived after ART, were included. National ART and medical birth registry data were cross-linked with data from other health and population registries. Outcomes were major CHDs, severe CHDs, 6 hierarchical CHD lesion groups, and 10 selected major CHDs, diagnosed prenatally or up to 1 year of age (Denmark, Finland, and Sweden) and prenatally or at birth (Norway). The association between ART and CHDs was assessed with multivariable logistic regression analysis, with adjustment for available confounders. Major CHDs were detected in 3159 children born after ART (1.84%) and in 86 824 children born after SC [1.15%; adjusted odds ratio (AOR) 1.36; 95% confidence interval (CI) 1.31-1.41]. Risk was highest in multiples, regardless of conception method. Severe CHDs were detected in 594 children born after ART (0.35%) and in 19 375 children born after SC (0.26%; AOR 1.30; 95% CI 1.20-1.42). Risk was similar between ICSI and IVF and between frozen and fresh embryo transfer. Assisted reproductive technology-conceived children have a higher prevalence of major CHDs, being rare, but severe conditions. The absolute risks are, however, modest and partly associated with multiple pregnancies, more prevalent in ART.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Children born after assisted reproductive technology (ART) have worse perinatal outcomes compared with spontaneously conceived children. This study investigates whether children conceived after ART have a higher risk of congenital heart defects (CHDs) compared with children born after spontaneous conception (SC).
METHODS METHODS
All 7 747 637 liveborn children in Denmark (1994-2014), Finland (1990-2014), Norway (1984-2015), and Sweden (1987-2015), where 171 735 children were conceived after ART, were included. National ART and medical birth registry data were cross-linked with data from other health and population registries. Outcomes were major CHDs, severe CHDs, 6 hierarchical CHD lesion groups, and 10 selected major CHDs, diagnosed prenatally or up to 1 year of age (Denmark, Finland, and Sweden) and prenatally or at birth (Norway). The association between ART and CHDs was assessed with multivariable logistic regression analysis, with adjustment for available confounders.
RESULTS RESULTS
Major CHDs were detected in 3159 children born after ART (1.84%) and in 86 824 children born after SC [1.15%; adjusted odds ratio (AOR) 1.36; 95% confidence interval (CI) 1.31-1.41]. Risk was highest in multiples, regardless of conception method. Severe CHDs were detected in 594 children born after ART (0.35%) and in 19 375 children born after SC (0.26%; AOR 1.30; 95% CI 1.20-1.42). Risk was similar between ICSI and IVF and between frozen and fresh embryo transfer.
CONCLUSIONS CONCLUSIONS
Assisted reproductive technology-conceived children have a higher prevalence of major CHDs, being rare, but severe conditions. The absolute risks are, however, modest and partly associated with multiple pregnancies, more prevalent in ART.

Identifiants

pubmed: 39326528
pii: 7773316
doi: 10.1093/eurheartj/ehae572
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nordic Trial Alliance
Organisme : Nordic Council of Ministers and NordForsk
ID : 71450
Organisme : Central Norway Regional Health Authorities
ID : 46045000
Organisme : Norwegian Cancer Society
ID : 182356-2016
Organisme : Nordic Federation of Obstetrics and Gynaecology
ID : NF13041
Organisme : Interreg Öresund-Kattegat-Skagerrak European Regional Development Fund
ID : ALFGBG-70940
Organisme : Hjalmar Svensson Foundation

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Nona Sargisian (N)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Diagnosvägen 14, 416 85 Gothenburg, Sweden.

Max Petzold (M)

School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

Eva Furenäs (E)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Center for Adults with Grown Up Congenital Heart Disease (ACHD/GUCH), Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

Mika Gissler (M)

Department of Knowledge Brokers, THL Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Academic Primary Health Care Centre, Region Stockholm, Stockholm, Sweden.

Anne Lærke Spangmose (AL)

Fertility Clinic, Department of Gynecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Sara Malchau Lauesgaard (S)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Diagnosvägen 14, 416 85 Gothenburg, Sweden.

Signe Opdahl (S)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.

Anja Pinborg (A)

Fertility Clinic, Department of Gynecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Anna-Karina A Henningsen (AA)

Fertility Clinic, Department of Gynecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Kjersti Westvik-Johari (K)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Fertility, Women and Children's Centre, St Olavs Hospital, Trondheim, Norway.

Kristiina Rönö (K)

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Christina Bergh (C)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Diagnosvägen 14, 416 85 Gothenburg, Sweden.

Ulla-Britt Wennerholm (UB)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Diagnosvägen 14, 416 85 Gothenburg, Sweden.

Classifications MeSH